As of Jun 22
| +0.48 / +0.41%|
The 14 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 116.00, with a high estimate of 130.00 and a low estimate of 95.00. The median estimate represents a -0.18% decrease from the last price of 116.21.
The current consensus among 18 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.